Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorUniversity of Miami

About this trial

The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.

Adults that is able to consent (≥ 18 years of age)

Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals

not currently immunosuppressed [White blood count (WBC) >= 2, not on immunosuppressive medications]

unable to consent and < 18 years of age

currently immunosuppressed (WBC < 2, not on immunosuppressive medications)

150 Participants

are grouped into 1 trial group

University of Miami

Lead sponsor